Institute of Pathology, University Hospital and University of Lausanne, Lausanne, Switzerland.
Institut Universitaire de Pathologie, CHUV, 25 rue du Bugnon, CH-1011, Lausanne, Switzerland.
Rev Endocr Metab Disord. 2021 Sep;22(3):527-538. doi: 10.1007/s11154-020-09612-2. Epub 2020 Nov 9.
Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplastic proliferations showing different morphological features, immunophenotype, molecular background, clinical presentation, and outcome. They can virtually originate in every organ of the human body and their classification is not uniform among different sites. Indeed, as they have historically been classified according to the organ in which they primarily arise, the different nomenclature that has resulted have created some confusion among pathologists and clinicians. Although a uniform terminology to classify neuroendocrine neoplasms arising in different systems has recently been proposed by WHO/IARC, some issues remain unsolved or need to be clarified. In this review, we discuss the lights and shadows of the current WHO classifications used to define and characterize NENs of the pituitary gland, lung, breast and those of the head and neck region, and digestive and urogenital systems.
神经内分泌肿瘤(NENs)是一组异质性的肿瘤增生,表现出不同的形态特征、免疫表型、分子背景、临床表现和预后。它们几乎可以起源于人体的每一个器官,而且它们的分类在不同的部位并不统一。事实上,由于它们历来是根据其主要起源的器官进行分类的,因此由此产生的不同命名法给病理学家和临床医生造成了一些混淆。尽管世界卫生组织/国际癌症研究机构(IARC)最近提出了一种用于分类不同系统中神经内分泌肿瘤的统一术语,但仍存在一些尚未解决或需要澄清的问题。在这篇综述中,我们讨论了目前用于定义和描述垂体、肺、乳腺和头颈部以及消化系统和泌尿生殖系统神经内分泌肿瘤的世界卫生组织分类的优缺点。